Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Certified by Founder
Lodge
Novoron Bioscience
start up
United States
- San Diego, California
- 16/11/2021
- Seed
- $3,000,000
Novoron Bioscience is a biotechnology company that develops pharmaceutical therapies to regenerate nerves of the central nervous system (CNS). We have received multiple Phase 1 grants from the National Institutes of Health (NIH) in order to pursue our passion: To develop our ground-breaking discovery into therapies that promote recovery for patients suffering from conditions resulting from a damaged CNS.
- Industry Biotechnology Research
- Website https://novoron.com/
- LinkedIn https://www.linkedin.com/company/novoron-bioscience/
Related People
Travis StilesFounder
United States -
San Diego, California,
Scientist turned entrepreneur. Founder Novoron Bioscience developing neuroregenerative therapies. Public speaker passionate about overcoming barriers to innovation and embracing the complexity of human disease towards improving the human condition.
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)